News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
777,795 Results
Type
Article (60190)
Company Profile (343)
Press Release (717249)
Multimedia
Podcasts (110)
Webinars (16)
Section
Business (218088)
Career Advice (2623)
Deals (37728)
Drug Delivery (126)
Drug Development (86474)
Employer Resources (179)
FDA (17591)
Job Trends (16249)
News (370634)
Policy (36186)
Tag
Academia (2937)
Accelerated approval (16)
Adcomms (31)
Allergies (109)
Alliances (53695)
ALS (129)
Alzheimer's disease (1604)
Antibody-drug conjugate (ADC) (184)
Approvals (17592)
Artificial intelligence (389)
Autoimmune disease (38)
Automation (22)
Bankruptcy (382)
Best Places to Work (12375)
BIOSECURE Act (20)
Biosimilars (137)
Biotechnology (232)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (419)
Cancer (3335)
Cardiovascular disease (264)
Career advice (2200)
Career pathing (33)
CAR-T (216)
CDC (39)
Cell therapy (572)
Cervical cancer (27)
Clinical research (71136)
Collaboration (1201)
Company closure (4)
Compensation (796)
Complete response letters (40)
COVID-19 (2888)
CRISPR (70)
C-suite (441)
Cystic fibrosis (128)
Data (3448)
Decentralized trials (2)
Denatured (40)
Depression (86)
Diabetes (387)
Diagnostics (6865)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (47)
Drug discovery (168)
Drug pricing (161)
Drug shortages (34)
Duchenne muscular dystrophy (171)
Earnings (91970)
Editorial (51)
Employer branding (22)
Employer resources (156)
Events (122953)
Executive appointments (924)
FDA (19713)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1070)
Gene editing (152)
Generative AI (31)
Gene therapy (460)
GLP-1 (934)
Government (5050)
Grass and pollen (7)
Guidances (328)
Healthcare (20527)
HIV (44)
Huntington's disease (31)
IgA nephropathy (50)
Immunology and inflammation (191)
Immuno-oncology (16)
Indications (44)
Infectious disease (3092)
Inflammatory bowel disease (171)
Inflation Reduction Act (11)
Influenza (79)
Intellectual property (145)
Interviews (443)
IPO (17450)
IRA (53)
Job creations (4268)
Job search strategy (1856)
Kidney cancer (15)
Labor market (60)
Layoffs (575)
Leadership (28)
Legal (8873)
Liver cancer (87)
Longevity (12)
Lung cancer (470)
Lymphoma (242)
Machine learning (16)
Management (61)
Manufacturing (497)
MASH (110)
Medical device (14692)
Medtech (14705)
Mergers & acquisitions (21071)
Metabolic disorders (992)
Multiple sclerosis (107)
NASH (21)
Neurodegenerative disease (164)
Neuropsychiatric disorders (46)
Neuroscience (2425)
NextGen: Class of 2025 (7268)
Non-profit (4965)
Now hiring (53)
Obesity (501)
Opinion (286)
Ovarian cancer (110)
Pain (139)
Pancreatic cancer (138)
Parkinson's disease (206)
Partnered (24)
Patents (360)
Patient recruitment (231)
Peanut (55)
People (62222)
Pharmaceutical (84)
Pharmacy benefit managers (25)
Phase I (22063)
Phase II (31197)
Phase III (23372)
Pipeline (2331)
Policy (252)
Postmarket research (2926)
Preclinical (9585)
Press Release (71)
Prostate cancer (163)
Psychedelics (43)
Radiopharmaceuticals (279)
Rare diseases (568)
Real estate (6591)
Recruiting (69)
Regulatory (25321)
Reports (53)
Research institute (2606)
Resumes & cover letters (422)
Rett syndrome (11)
RNA editing (14)
RSV (60)
Schizophrenia (110)
Series A (179)
Series B (130)
Service/supplier (14)
Sickle cell disease (69)
Special edition (24)
Spinal muscular atrophy (163)
Sponsored (36)
Startups (4113)
State (2)
Stomach cancer (17)
Supply chain (85)
Tariffs (77)
The Weekly (68)
Vaccines (956)
Venture capital (61)
Weight loss (340)
Women's health (52)
Worklife (19)
Date
Today (112)
Last 7 days (562)
Last 30 days (2663)
Last 365 days (32606)
2025 (21272)
2024 (36973)
2023 (41965)
2022 (53282)
2021 (58053)
2020 (56921)
2019 (50273)
2018 (38181)
2017 (35170)
2016 (35387)
2015 (41307)
2014 (35133)
2013 (30601)
2012 (32786)
2011 (33408)
2010 (32057)
Location
Africa (935)
Alabama (68)
Alaska (7)
Arizona (271)
Arkansas (14)
Asia (44157)
Australia (7398)
California (8411)
Canada (2601)
China (784)
Colorado (359)
Connecticut (378)
Delaware (228)
Europe (98024)
Florida (1261)
Georgia (293)
Hawaii (2)
Idaho (65)
Illinois (733)
India (39)
Indiana (404)
Iowa (18)
Japan (253)
Kansas (117)
Kentucky (32)
Louisiana (17)
Maine (65)
Maryland (1168)
Massachusetts (6327)
Michigan (270)
Minnesota (517)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (25)
Nevada (95)
New Hampshire (74)
New Jersey (2330)
New Mexico (30)
New York (2323)
North Carolina (1253)
North Dakota (10)
Northern California (3757)
Ohio (261)
Oklahoma (17)
Oregon (40)
Pennsylvania (1799)
Puerto Rico (18)
Rhode Island (41)
South America (1323)
South Carolina (43)
South Dakota (1)
Southern California (3198)
Tennessee (138)
Texas (1307)
United States (31284)
Utah (251)
Virginia (217)
Washington D.C. (79)
Washington State (715)
West Virginia (4)
Wisconsin (77)
777,795 Results for "ra medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
August 26, 2025
·
6 min read
Press Releases
Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors
July 1, 2025
·
13 min read
Press Releases
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
August 13, 2025
·
8 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
August 21, 2025
·
1 min read
Press Releases
Aquedeon Medical Inc. Receives FDA Approval to Expand Clinical Trial of Duett Vascular Graft System
August 13, 2025
·
2 min read
Press Releases
Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addicted Cancers
June 25, 2025
·
9 min read
Press Releases
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
August 12, 2025
·
10 min read
Press Releases
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
August 5, 2025
·
17 min read
Press Releases
Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC
June 17, 2025
·
7 min read
Press Releases
Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
July 29, 2025
·
8 min read
1 of 77,780
Next
